Literature DB >> 6092702

Molecular cloning and characterization of the DNAs of human papillomaviruses 19, 20, and 25 from a patient with epidermodysplasia verruciformis.

A Gassenmaier, M Lammel, H Pfister.   

Abstract

Five human papillomavirus (HPV) DNAs from lesions of an epidermodysplasia verruciformis patient were cloned in lambda L 47: DNA of HPV 5, which predominated in the carcinoma; DNA of a variant type of HPV 8, which was not detected in the carcinoma DNA by Southern blot hybridization but only by cloning; and DNAs of three papillomaviruses that were isolated from warts. Southern blot and liquid phase DNA-DNA hybridization under stringent conditions showed that the three viruses from warts were new types, which we named HPVs 19, 20, and 25. These viruses cross-hybridized between 3 and 29% among themselves and with HPVs 5 and 8. After physical mapping with several restriction enzymes, the colinear genomes were aligned with HPV 8 DNA to define early and late regions. HPVs 8, 19, and 25 shared homology in different parts of their genomes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092702      PMCID: PMC254634     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  14 in total

1.  EBV DNA in nonlymphoid cells of nasopharyngeal carcinomas and in a malignant lymphoma obtained after inoculation of EBV into cottontop marmosets.

Authors:  H Wolf; J Werner; H zur Hausen
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis.

Authors:  G Orth; S Jablonska; M Favre; O Croissant; M Jarzabek-Chorzelska; G Rzesa
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

Review 4.  Epidermodysplasia verruciformis. An autosomal recessive disease characterized by viral warts and skin cancer. A model for viral oncogenesis.

Authors:  M A Lutzner
Journal:  Bull Cancer       Date:  1978       Impact factor: 1.276

5.  Viral DNA in transformed cells. I. A study of the sequences of adenovirus 2 DNA in a line of transformed rat cells using specific fragments of the viral genome.

Authors:  P A Sharp; U Pettersson; J Sambrook
Journal:  J Mol Biol       Date:  1974-07-15       Impact factor: 5.469

6.  Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma.

Authors:  L Gissmann; V Diehl; H J Schultz-Coulon; H zur Hausen
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

7.  New human papilloma virus isolated from epidermodysplasia verruciformis lesions.

Authors:  M Yutsudo; T Tanigaki; T Tsumori; S Watanabe; A Hakura
Journal:  Cancer Res       Date:  1982-06       Impact factor: 12.701

8.  Biochemical characterization of two types of human papillomaviruses associated with epidermodysplasia verruciformis.

Authors:  D Kremsdorf; S Jablonska; M Favre; G Orth
Journal:  J Virol       Date:  1982-08       Impact factor: 5.103

9.  Human papillomavirus DNA in cutaneous primary and metastasized squamous cell carcinomas from patients with epidermodysplasia verruciformis.

Authors:  R S Ostrow; M Bender; M Niimura; T Seki; M Kawashima; F Pass; A J Faras
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

10.  Characterization of a human papillomavirus from epidermodysplasia verruciformis lesions of a patient from Upper-volta.

Authors:  H Pfister; F Nürnberger; L Gissmann; H zur Hausen
Journal:  Int J Cancer       Date:  1981-05-15       Impact factor: 7.396

View more
  15 in total

Review 1.  The molecular biology of human papillomaviruses and the pathogenesis of genital papillomas and neoplasms.

Authors:  R S Ostrow; A J Faras
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 2.  Heterogeneity of the human papillomavirus group.

Authors:  E M de Villiers
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

Review 3.  Human papillomavirus and skin cancer.

Authors:  J M McGregor; M H Rustin
Journal:  Postgrad Med J       Date:  1994-10       Impact factor: 2.401

4.  Human papillomavirus 25-related DNA in solitary keratoacanthoma.

Authors:  A Gassenmaier; H Pfister; O P Hornstein
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

5.  Analysis of benign and malignant urogenital tumors for human papillomavirus infection by labelling cellular DNA.

Authors:  E M de Villiers; A Schneider; G Gross; H zur Hausen
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

6.  Epidermodysplasia verruciformis-associated human papillomavirus 8: genomic sequence and comparative analysis.

Authors:  P G Fuchs; T Iftner; J Weninger; H Pfister
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

7.  Papillomavirus DNA in warts of immunosuppressed renal allograft recipients.

Authors:  A Gassenmaier; P Fuchs; H Schell; H Pfister
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

8.  Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients.

Authors:  R J Berkhout; L M Tieben; H L Smits; J N Bavinck; B J Vermeer; J ter Schegget
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

9.  Molecular cloning and characterization of the genomes of nine newly recognized human papillomavirus types associated with epidermodysplasia verruciformis.

Authors:  D Kremsdorf; M Favre; S Jablonska; S Obalek; L A Rueda; M A Lutzner; C Blanchet-Bardon; P C Van Voorst Vader; G Orth
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

10.  Epidermodysplasia verruciformis: Langerhans cells, immunologic effect of retinoid treatment and cytogenetics.

Authors:  P C van Voorst Vader; M C de Jong; R Blanken; C G Kallenberg; A Vermey; J M Scheres
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.